Other: Mangafodipir trisodium ( DrugBank: Mangafodipir )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 58 | Hypertrophic cardiomyopathy | 1 |
58. Hypertrophic cardiomyopathy
Clinical trials : 119 / Drugs : 163 - (DrugBank : 45) / Drug target genes : 48 - Drug target pathways : 161
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03607669 (ClinicalTrials.gov) | June 1, 2018 | 20/7/2018 | Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium | Manganese-Enhanced Magnetic Resonance Imaging: Applications in Cardiomyopathy | Ischemic Cardiomyopathy;Dilated Cardiomyopathy;Hypertrophic Cardiomyopathy | Other: Mangafodipir trisodium | University of Edinburgh | NULL | Unknown status | 18 Years | 65 Years | All | 90 | United Kingdom |